Apellis Pharmaceuticals Inc Forecast and Target Price
$30.07
Apellis Pharmaceuticals Inc (APLS) Share Price Forecast
Currently 23 wall-street analysts regularly analyze the financials of Apellis Pharmaceuticals Inc on a frequent basis to provide recommendations along with target share price. 23 analysts offering 12-month price forecasts for Apellis Pharmaceuticals Inc (APLS) have a share price target of $38.06. This median of share price forecast represents a 26.56% upside from the latest price of $30.07 as on 29.10.25.
Apellis Pharmaceuticals Inc (APLS) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Apellis Pharmaceuticals Inc (APLS) share price will touch around $38.06 in next 12-months.
Apellis Pharmaceuticals Inc (APLS) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Apellis Pharmaceuticals Inc's share price and its median forecast price. As on 29.10.25, the difference is -39.3%
Apellis Pharmaceuticals Inc (APLS): Difference between Current Price & Median Forecasted Price
Apellis Pharmaceuticals Inc (APLS) Share Price : Analyst Recommendation
Based on 23 analysts tracking and researching Apellis Pharmaceuticals Inc (APLS) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 10 | 10 | 10 |
| Outperform | 8 | 9 | 9 |
| Hold | 5 | 4 | 4 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |